{"id":507491,"date":"2021-06-29T07:03:40","date_gmt":"2021-06-29T11:03:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/"},"modified":"2021-06-29T07:03:40","modified_gmt":"2021-06-29T11:03:40","slug":"microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/","title":{"rendered":"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">HINGHAM, Mass., June  29, 2021  (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company\u2019s innovative \u2018One &amp; Done\u2019 guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued\/allowed and 24 pending patent applications.<\/p>\n<p align=\"justify\">\u201cThis latest patent allowance will expand protection of our One &amp; Done technology, while we pursue solutions that provide better patient outcomes and healthcare economics,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cWe secured three patents in the last year that we believe have strengthened our place in large addressable markets, and we intend to continue to strategically pursue more jurisdictions to create further barriers for entry to fortify our competitive advantage.\u201d<\/p>\n<p align=\"justify\">The allowed claims cover a double guidewire comprising a first hollow guidewire (outer tube) and a second guidewire (inner tube), each of the first and second guidewire is pre-shaped to impart a lateral deflection to its distal portion. An adjuster mechanism is operable to displace the inner tube longitudinally relative to the outer tube between at least three states. Each such state displaces the deflection of the outer and the deflection of the inner tube relative to each other, thereby adjusting the properties of curvature and stiffness of the distal portion of the entire double guidewire.<\/p>\n<p>\n        <strong>About Microbot Medical<\/strong>\n      <\/p>\n<p align=\"justify\">Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot\u2019s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).<\/p>\n<p align=\"justify\">Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=clIJ4nXA3b5u7r_T8pLqM5NJpbl4tE9ky7VM7V8efpFbqFmiVdvPQErXLT_tX4F_khZifxSdywwhS3pnbcEcf0CX4uVHc2A_z3aq__lSVW4=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.microbotm<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j3xAqxLTgXDdf_WwZvbfNUo6yKJKb0fS0haooaE2_S7v40JaU2naSGs3trwXH442ccmO-LUg0_n12bHwov96ag==\" rel=\"nofollow noopener\" target=\"_blank\">edical.com<\/a>.<\/p>\n<p>\n        <strong>Safe Harbor<\/strong>\n      <\/p>\n<p align=\"justify\">Statements pertaining to the registered direct offering, timing, the amount and anticipated use of proceeds and statements pertaining to future financial and\/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as \u201cwill,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cexpects\u201d and \u201cestimates\u201d) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions and the satisfaction of customary closing conditions, risks inherent in the development and\/or commercialization of potential products, including LIBERTY and SCS, the outcome of its studies to evaluate LIBERTY, SCS and other existing and future technologies, uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading \u201cRisk Factors\u201d in Microbot Medical\u2019s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC\u2019s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Michael Polyviou<br \/>EVC Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UyfYJ9FVjDTJN4PJEOWbHn-_trWaGGnPEFL23GuMIghtvM8RpSVJMHTqX6y9oQ4pSzRdyGmlhk7vdH69ZLMOiCLMVj5GlsGWcxxFnMvzegg=\" rel=\"nofollow noopener\" target=\"_blank\">mpolyviou@evcgroup.com<\/a>\u00a0<br \/>732-933-2754<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/42ff904f-51f3-4884-9724-0f211cc8e58d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company\u2019s innovative \u2018One &amp; Done\u2019 guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued\/allowed and 24 pending patent applications. \u201cThis latest patent allowance will expand protection of our One &amp; Done technology, while we pursue solutions that provide better patient outcomes and healthcare economics,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cWe secured three patents in the last year that we believe have strengthened our place in large addressable markets, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-507491","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company\u2019s innovative \u2018One &amp; Done\u2019 guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued\/allowed and 24 pending patent applications. \u201cThis latest patent allowance will expand protection of our One &amp; Done technology, while we pursue solutions that provide better patient outcomes and healthcare economics,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cWe secured three patents in the last year that we believe have strengthened our place in large addressable markets, &hellip; Continue reading &quot;Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-29T11:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology\",\"datePublished\":\"2021-06-29T11:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/\"},\"wordCount\":613,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/\",\"name\":\"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=\",\"datePublished\":\"2021-06-29T11:03:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/","og_locale":"en_US","og_type":"article","og_title":"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology - Market Newsdesk","og_description":"HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company\u2019s innovative \u2018One &amp; Done\u2019 guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued\/allowed and 24 pending patent applications. \u201cThis latest patent allowance will expand protection of our One &amp; Done technology, while we pursue solutions that provide better patient outcomes and healthcare economics,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cWe secured three patents in the last year that we believe have strengthened our place in large addressable markets, &hellip; Continue reading \"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-29T11:03:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology","datePublished":"2021-06-29T11:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/"},"wordCount":613,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/","name":"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=","datePublished":"2021-06-29T11:03:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTU3NyM0MjcyNDYxIzIwODIxMTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021-to-recognize-novelty-of-one-done-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of \u2018One &amp; Done\u2019 Technology"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/507491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=507491"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/507491\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=507491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=507491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=507491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}